Skip to main content
. Author manuscript; available in PMC: 2020 Jun 29.
Published in final edited form as: J Immunother. 2010 May;33(4):435–441. doi: 10.1097/CJI.0b013e3181d32f01

TABLE 2.

PFS, OS, and rOS for the 2 Treatment Arms GOLFIG and FOLFOX Stratified for FoxP3 Expression High or Low

Treatment FoxP3+ Expression Score OS rOS PFS
FOLFOX Low Mean 25.4 (95% CI 17–33.8), median 21 Mean 17.5 (95% CI 11.4–23.5), median 15 Mean 8.3 (95% CI 4.5–12.2), median 5.0
High Mean 31.4 (95% CI 18.2–44.5), median 28 Mean 19.2 (95% CI 13.8–24.6), median 22.5 Mean 12.4 (95% CI 8.6–16.2), median 12.5
P = 0.0025* P = 0.0088* P = 0.0421*
GOLFIG Low Mean 39.8 (95% CI 9.9–69.6), median 27.5 Mean 20.6 (95% CI 10.2–31.1), median 20.5 Mean 10.6 (95% CI 5.9–15.3), median 11.0
High Mean 51 (95% CI 32.5–69.5), median 41 Mean 25.7 (95% CI 17.3–34), median 24.5 Mean 18.1 (95% CI 11.1–25.1), median 12.0
P = 0.1528 P = 0.0828 P = 0.0340*
*

Statistically significant values.

CI indicates confidence interval; OS, overall survival; rOS, treatment-relative survival; PSF, progression-free survival.